XENE
Xenon Pharmaceuticals Inc Earnings
$37.66
Earnings Summary
Revenue | $0Mn |
Net Profits | $-84.71Mn |
Net Profit Margins | -Inf% |
Xenon Pharmaceuticals Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q2 2025. On a quarterly growth basis, Xenon Pharmaceuticals Inc has generated -100% fall in its revenue since last 3-months.
Xenon Pharmaceuticals Inc’s net profit fell -46.24% since last year same period to $-84.71Mn in the Q2 2025. On a quarterly growth basis, Xenon Pharmaceuticals Inc has generated -30.22% fall in its net profits since last 3-months.
Xenon Pharmaceuticals Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q2 2025. On a quarterly growth basis, Xenon Pharmaceuticals Inc has generated -Inf% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -1.06 |
EPS Estimate Current Year | -1.06 |
Xenon Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -1.06 - a -7.07% fall from last quarter’s estimates.
Xenon Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -1.06.
Key Ratios
Earning Per Share (EPS) | 0 |
Xenon Pharmaceuticals Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Xenon Pharmaceuticals Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-05-12 | -0.9 | -0.83 | 7.49% |
2025-11-05 | -1.06 | 0 | 100% |
2025-08-11 | -0.99 | 1.07 | 208.08% |
